XETRA - Delayed Quote EUR

Evonik Industries AG (EVK.DE)

Compare
20.60 +0.14 (+0.68%)
At close: October 25 at 5:35 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Christian Kullmann CEO & Chairman of the Executive Board 2.58M -- 1969
Dr. Harald Schwager Deputy Chairman of the Executive Board 2.17M -- 1960
Maike Schuh CFO & Member of Executive Board 1.04M -- --
Mr. Thomas Wessel Chief Human Resources Officer, Labor Relations Director & Member of Executive Board 1.41M -- 1963
Dr. Wilfried Ostendorf Head of Production and Technology -- -- --
Mr. Tim Lange Head of Investor Relations -- -- --
Mr. Thomas Mahlstedt Vice President M&A, Corporate Legal & Compliance -- -- --
Christian Schmid Head of Corporate Communications -- -- 1971
Dr. Stefan Mack Head of the Methionine & Derivatives Product Line -- -- --
Mr. Matthias Ruch Head of External Communications & Corporate Press Officer -- -- --

Evonik Industries AG

Rellinghauser Strasse 1-11
Essen, 45128
Germany
49 201 177 3315 https://corporate.evonik.com
Full Time Employees:?
32,757

Description

Evonik Industries AG produces specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure segments. The Specialty Additives segment provides additives for polyurethane; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depressants, and viscosity index improvers for coatings for oil and other lubricants for construction machinery and automotive sector. The Nutrition & Care segment offers D-/l-methionine and lysine for animal nutrition industry; amino acids and peptides; pharmaceutical active ingredients; and biocompatible and bioresorbable materials for orthopedic and medical applications; and system solutions for the cosmetics and detergent industries. The Smart Materials segment provides inorganic materials, including fumed and precipitated silicas and silanes; peroxides for paper and textile industries; specialty catalysts for synthesis and alkoxides; polymers products, such as polymide 12, polymer foam, specialty polybutadiene and polyester, alkoxides, and membranes. The Performance Materials offers C4 derivatives consisting of butadiene, MTBE, butene-1, isononanol, and DINP for use in automotive industry; and superabsorbent products for diapers and hygiene products. The Technology & Infrastructure segment provides energy management, integrated plant support and maintenance, process safety and engineering, pipelines, transport management, logistics safety, digital solutions for chemical production, and strategic site development services. The company was founded in 1873 and is headquartered in Essen, Germany.

Corporate Governance

Evonik Industries AG’s ISS Governance QualityScore as of October 1, 2024 is 7. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 6; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 6, 2024 at 6:00 AM UTC

Evonik Industries AG Earnings Date

Recent Events

June 5, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers